Living Cell Technologies Hosts Diabetes Seminar for World Leaders in Porcine Islet Implants in Humans
July 17, 2008, Melbourne, Australia and Auckland, New Zealand. Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK)
today announced that Professor Bob Elliott, Medical Director of LCT, will host a seminar on Friday August 8, 2008 in
Auckland, New Zealand for world leading medical scientists and specialists to discuss current developments with porcine
islet transplant technologies.
The one day meeting brings together experts with many years' experience who are developing methods for delivering
insulin producing cells to patients with insulin dependant Type 1 diabetes. The topics they will address include the
health status of the pigs whose insulin producing cells are implanted into humans, the absence of immunosuppression
drugs, early clinical data from human studies and post transplant monitoring.
World leading experts, Professor David White, Robarts Institute Canada, Professor Gregory Korbutt, University of
Alberta, Canada, Professor Nikolai Skaletsky, the Sklifosovsky Institute, Moscow, Professor Riccaardo Calafiore,
University of Perugia, Italy and Dr Linda Scobie, University of Glasgow, will be presenting at the seminar, among
others.
Professor Elliott said: "We are delighted to have so many islet implant experts participating in this meeting which will
be very focused on the issues surrounding human trials. The early results that have been obtained to date from LCT's
porcine islet implants have been extremely encouraging. I look forward to discussing the results with fellow scientists
and practitioners who see the importance of islet cell treatment and are keen to advance this technology rapidly for the
benefit of people with insulin dependent Type 1 diabetes."
ENDS